2018-02-22 |
2018-02-20 |
PS
Planned sale
|
Swan Winifred L
SVP and General Counsel
|
3,500
-26.4%
24.48
USD 85,680
|
3,500
-26.4%
|
24.48
|
USD 85,680
|
|
2018-01-19 |
2018-01-16 |
PS
Planned sale
|
Swan Winifred L
SVP and General Counsel
|
3,500
-25.4%
24.88
USD 87,080
|
3,500
-25.4%
|
24.88
|
USD 87,080
|
|
2017-12-21 |
2017-12-20 |
PS
Planned sale
|
Swan Winifred L
SVP and General Counsel
|
3,500
-24.5%
25.35
USD 88,725
|
3,500
-24.5%
|
25.35
|
USD 88,725
|
|
2017-11-15 |
2017-11-15 |
PS
Planned sale
|
Swan Winifred L
SVP and General Counsel
|
3,500
-23.7%
25.73
USD 90,055
|
3,500
-23.7%
|
25.73
|
USD 90,055
|
|
2017-10-23 |
2017-10-20 |
PS
Planned sale
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4,030
-14.2%
27.50
USD 110,825
|
4,030
-14.2%
|
27.50
|
USD 110,825
|
|
2017-10-23 |
2017-10-20 |
PS
Planned sale
|
Swan Winifred L
SVP and General Counsel
|
3,500
-22.9%
27.50
USD 96,250
|
3,500
-22.9%
|
27.50
|
USD 96,250
|
|
2017-10-04 |
2017-10-04 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
1,000
-1.4%
27.56
USD 27,560
|
1,000
-1.4%
|
27.56
|
USD 27,560
|
|
2017-09-21 |
2017-09-20 |
PS
Planned sale
|
Swan Winifred L
SVP and General Counsel
|
3,500
-22.2%
27.27
USD 95,445
|
3,500
-22.2%
|
27.27
|
USD 95,445
|
|
2017-09-21 |
2017-09-20 |
PS
Planned sale
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4,300
-15.0%
27.27
USD 117,261
|
4,300
-15.0%
|
27.27
|
USD 117,261
|
|
2017-09-05 |
2017-09-05 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
1,000
-1.3%
27.95
USD 27,950
|
1,000
-1.3%
|
27.95
|
USD 27,950
|
|
2017-08-23 |
2017-08-21 |
PS
Planned sale
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4,300
-15.0%
29.22
USD 125,646
|
4,300
-15.0%
|
29.22
|
USD 125,646
|
|
2017-08-15 |
2017-08-15 |
PS
Planned sale
|
Swan Winifred L
SVP and General Counsel
|
3,500
-21.5%
29.21
USD 102,235
|
3,500
-21.5%
|
29.21
|
USD 102,235
|
|
2017-08-10 |
2017-08-10 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
1,000
-1.3%
29.26
USD 29,260
|
1,000
-1.3%
|
29.26
|
USD 29,260
|
|
2017-08-08 |
2017-08-07 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
18,000
-19.2%
29.63
USD 533,340
|
18,000
-19.2%
|
29.63
|
USD 533,340
|
|
2017-08-08 |
2017-08-07 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
6,000
-6.0%
29.66
USD 177,960
|
6,000
-6.0%
|
29.66
|
USD 177,960
|
|
2017-08-04 |
2017-08-03 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
7,000
-8.4%
22.98
USD 160,860
|
7,000
-8.4%
|
22.98
|
USD 160,860
|
|
2017-07-21 |
2017-07-20 |
PS
Planned sale
|
Swan Winifred L
SVP and General Counsel
|
3,500
-20.9%
24.16
USD 84,560
|
3,500
-20.9%
|
24.16
|
USD 84,560
|
|
2017-07-21 |
2017-07-20 |
PS
Planned sale
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4,300
-15.0%
24.16
USD 103,888
|
4,300
-15.0%
|
24.16
|
USD 103,888
|
|
2017-07-07 |
2017-07-05 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
1,000
-1.3%
25.19
USD 25,190
|
1,000
-1.3%
|
25.19
|
USD 25,190
|
|
2017-06-21 |
2017-06-20 |
PS
Planned sale
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4,300
-14.5%
23.29
USD 100,147
|
4,300
-14.5%
|
23.29
|
USD 100,147
|
|
2017-06-16 |
2017-06-15 |
PS
Planned sale
|
Swan Winifred L
SVP and General Counsel
|
3,500
-20.3%
23.14
USD 80,990
|
3,500
-20.3%
|
23.14
|
USD 80,990
|
|
2017-07-07 |
2017-06-14 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
1,000
-1.3%
23.74
USD 23,740
|
1,000
-1.3%
|
23.74
|
USD 23,740
|
|
2017-06-12 |
2017-06-08 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
2,250
-2.8%
23.59
USD 53,078
|
2,250
-2.8%
|
23.59
|
USD 53,078
|
|
2017-05-23 |
2017-05-22 |
PS
Planned sale
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4,300
-14.5%
21.36
USD 91,848
|
4,300
-14.5%
|
21.36
|
USD 91,848
|
|
2017-05-15 |
2017-05-15 |
PS
Planned sale
|
Swan Winifred L
SVP and General Counsel
|
3,500
-19.7%
21.94
USD 76,790
|
3,500
-19.7%
|
21.94
|
USD 76,790
|
|
2017-05-11 |
2017-05-10 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
250
-0.3%
23.59
USD 5,898
|
250
-0.3%
|
23.59
|
USD 5,898
|
|
2017-05-04 |
2017-05-03 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
1,000
-1.3%
29.95
USD 29,950
|
1,000
-1.3%
|
29.95
|
USD 29,950
|
|
2017-04-21 |
2017-04-20 |
PS
Planned sale
|
Burbank Jeffrey H
Chief Executive Officer
|
3,000
-0.3%
27.28
USD 81,840
|
3,000
-0.3%
|
27.28
|
USD 81,840
|
|
2017-04-20 |
2017-04-20 |
PS
Planned sale
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4,300
-14.5%
27.28
USD 117,304
|
4,300
-14.5%
|
27.28
|
USD 117,304
|
|
2017-04-20 |
2017-04-20 |
PS
Planned sale
|
Swan Winifred L
SVP and General Counsel
|
3,500
-19.2%
27.28
USD 95,480
|
3,500
-19.2%
|
27.28
|
USD 95,480
|
|
2017-04-20 |
2017-04-19 |
PS
Planned sale
|
Burbank Jeffrey H
Chief Executive Officer
|
3,000
-0.3%
26.65
USD 79,950
|
3,000
-0.3%
|
26.65
|
USD 79,950
|
|
2017-04-14 |
2017-04-13 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
1,000
-1.3%
26.10
USD 26,100
|
1,000
-1.3%
|
26.10
|
USD 26,100
|
|
2017-04-04 |
2017-04-03 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
14,397
-51.4%
26.60
USD 382,960
|
14,397
-51.4%
|
26.60
|
USD 382,960
|
|
2017-03-23 |
2017-03-22 |
PS
Planned sale
|
Burbank Jeffrey H
Chief Executive Officer
|
3,000
-0.3%
27.42
USD 82,260
|
3,000
-0.3%
|
27.42
|
USD 82,260
|
|
2017-03-22 |
2017-03-21 |
PS
Planned sale
|
Burbank Jeffrey H
Chief Executive Officer
|
3,000
-0.3%
27.72
USD 83,160
|
3,000
-0.3%
|
27.72
|
USD 83,160
|
|
2017-03-22 |
2017-03-20 |
PS
Planned sale
|
Swan Winifred L
SVP and General Counsel
|
15,723
-50.7%
27.66
USD 434,898
|
15,723
-50.7%
|
27.66
|
USD 434,898
|
|
2017-03-22 |
2017-03-20 |
PS
Planned sale
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4,300
-14.5%
27.66
USD 118,938
|
4,300
-14.5%
|
27.66
|
USD 118,938
|
|
2017-03-16 |
2017-03-16 |
S
Sale
|
MOORE CRAIG W
|
1,000
-1.0%
27.93
USD 27,930
|
1,000
-1.0%
|
27.93
|
USD 27,930
|
|
2017-03-08 |
2017-03-08 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
1,000
-1.2%
27.53
USD 27,530
|
1,000
-1.2%
|
27.53
|
USD 27,530
|
|
2017-03-07 |
2017-03-07 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
20,000
-55.4%
27.75
USD 555,000
|
20,000
-55.4%
|
27.75
|
USD 555,000
|
|
2017-03-06 |
2017-03-06 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
6,390
-28.4%
28.01
USD 178,984
|
6,390
-28.4%
|
28.01
|
USD 178,984
|
|
2017-02-24 |
2017-02-23 |
PS
Planned sale
|
Burbank Jeffrey H
Chief Executive Officer
|
7,500
-0.8%
28.97
USD 217,275
|
7,500
-0.8%
|
28.97
|
USD 217,275
|
|
2017-02-23 |
2017-02-22 |
PS
Planned sale
|
Burbank Jeffrey H
Chief Executive Officer
|
7,500
-0.8%
29.01
USD 217,575
|
7,500
-0.8%
|
29.01
|
USD 217,575
|
|
2017-02-23 |
2017-02-21 |
PS
Planned sale
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4,300
-18.7%
29.26
USD 125,818
|
4,300
-18.7%
|
29.26
|
USD 125,818
|
|
2017-02-21 |
2017-02-17 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
6,000
-8.0%
29.66
USD 177,960
|
6,000
-8.0%
|
29.66
|
USD 177,960
|
|
2017-02-15 |
2017-02-15 |
PS
Planned sale
|
Swan Winifred L
SVP and General Counsel
|
16,049
-60.5%
28.01
USD 449,532
|
16,049
-60.5%
|
28.01
|
USD 449,532
|
|
2017-02-15 |
2017-02-14 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
2,448
-12.4%
28.28
USD 69,229
|
2,448
-12.4%
|
28.28
|
USD 69,229
|
|
2017-02-13 |
2017-02-10 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
2,500
-3.5%
28.59
USD 71,475
|
2,500
-3.5%
|
28.59
|
USD 71,475
|
|
2017-02-13 |
2017-02-09 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
1,000
-1.4%
27.77
USD 27,770
|
1,000
-1.4%
|
27.77
|
USD 27,770
|
|
2017-02-08 |
2017-02-08 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
3,054
-13.4%
27.61
USD 84,321
|
3,054
-13.4%
|
27.61
|
USD 84,321
|
|
2017-02-07 |
2017-02-07 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
3,117
-12.0%
27.54
USD 85,842
|
3,117
-12.0%
|
27.54
|
USD 85,842
|
|
2017-02-06 |
2017-02-06 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
3,283
-11.2%
27.29
USD 89,593
|
3,283
-11.2%
|
27.29
|
USD 89,593
|
|
2017-02-06 |
2017-02-03 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
13,000
-30.8%
26.77
USD 348,010
|
13,000
-30.8%
|
26.77
|
USD 348,010
|
|
2017-02-02 |
2017-02-02 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
17,745
-37.8%
26.72
USD 474,146
|
17,745
-37.8%
|
26.72
|
USD 474,146
|
|
2017-02-02 |
2017-02-02 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
15,669
-18.2%
26.19
USD 410,371
|
15,669
-18.2%
|
26.19
|
USD 410,371
|
|
2017-02-02 |
2017-02-01 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
19,602
-36.6%
26.65
USD 522,393
|
19,602
-36.6%
|
26.65
|
USD 522,393
|
|
2017-01-26 |
2017-01-26 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
7,000
-14.7%
26.25
USD 183,750
|
7,000
-14.7%
|
26.25
|
USD 183,750
|
|
2017-01-26 |
2017-01-25 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
20,000
-33.0%
26.13
USD 522,600
|
20,000
-33.0%
|
26.13
|
USD 522,600
|
|
2017-01-26 |
2017-01-24 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
15,000
-27.0%
25.86
USD 387,900
|
15,000
-27.0%
|
25.86
|
USD 387,900
|
|
2017-01-23 |
2017-01-23 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
15,000
-27.0%
25.74
USD 386,100
|
15,000
-27.0%
|
25.74
|
USD 386,100
|
|
2017-01-23 |
2017-01-20 |
PS
Planned sale
|
Swan Winifred L
SVP and General Counsel
|
3,500
-24.2%
26.19
USD 91,665
|
3,500
-24.2%
|
26.19
|
USD 91,665
|
|
2017-01-23 |
2017-01-20 |
PS
Planned sale
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4,300
-18.7%
26.19
USD 112,617
|
4,300
-18.7%
|
26.19
|
USD 112,617
|
|
2017-01-23 |
2017-01-19 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
200
-0.5%
27.91
USD 5,582
|
200
-0.5%
|
27.91
|
USD 5,582
|
|
2017-01-23 |
2017-01-19 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
6,415
-13.6%
27.23
USD 174,680
|
6,415
-13.6%
|
27.23
|
USD 174,680
|
|
2017-01-18 |
2017-01-18 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
8,183
-14.8%
27.58
USD 225,687
|
8,183
-14.8%
|
27.58
|
USD 225,687
|
|
2017-01-18 |
2017-01-18 |
PS
Planned sale
|
Burbank Jeffrey H
Chief Executive Officer
|
7,500
-0.9%
27.63
USD 207,225
|
7,500
-0.9%
|
27.63
|
USD 207,225
|
|
2017-01-17 |
2017-01-17 |
PS
Planned sale
|
Brown Robert S.
President, NxStage Kidney Care
|
10,805
-16.3%
27.72
USD 299,515
|
10,805
-16.3%
|
27.72
|
USD 299,515
|
|
2017-01-17 |
2017-01-17 |
PS
Planned sale
|
Burbank Jeffrey H
Chief Executive Officer
|
7,500
-0.8%
27.52
USD 206,400
|
7,500
-0.8%
|
27.52
|
USD 206,400
|
|
2017-01-17 |
2017-01-13 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
7,500
-9.6%
28.00
USD 210,000
|
7,500
-9.6%
|
28.00
|
USD 210,000
|
|
2017-01-11 |
2017-01-11 |
PS
Planned sale
|
Turk Joseph E Jr
President
|
1,000
-1.3%
27.77
USD 27,770
|
1,000
-1.3%
|
27.77
|
USD 27,770
|
|
2016-12-20 |
2016-12-20 |
PS
Planned sale
|
TOWSE MATTHEW W
SVP and Chief Financial Office
Officer
|
4,300
-18.7%
25.55
USD 109,865
|
4,300
-18.7%
|
25.55
|
USD 109,865
|
|
2016-12-16 |
2016-12-15 |
PS
Planned sale
|
Swan Winifred L
SVP and General Counsel
Officer
|
3,500
-23.4%
25.91
USD 90,685
|
3,500
-23.4%
|
25.91
|
USD 90,685
|
|
2016-12-14 |
2016-12-14 |
PS
Planned sale
|
Burbank Jeffrey H
Chief Executive Officer
Executive Director
|
7,500
-0.8%
25.68
USD 192,600
|
7,500
-0.8%
|
25.68
|
USD 192,600
|
|
2016-12-13 |
2016-12-13 |
PS
Planned sale
|
Turk Joseph E Jr
President
Officer
|
1,000
-1.3%
25.42
USD 25,420
|
1,000
-1.3%
|
25.42
|
USD 25,420
|
|
2016-12-13 |
2016-12-13 |
PS
Planned sale
|
Burbank Jeffrey H
Chief Executive Officer
Executive Director
|
7,500
-0.8%
25.42
USD 190,650
|
7,500
-0.8%
|
25.42
|
USD 190,650
|
|